Jen Barger Fleming
About Jen Barger Fleming
Jen Barger Fleming is a Scientist II at Asklepios BioPharmaceutical, Inc., with a PhD in Cancer & Cell Biology from the University of Cincinnati College of Medicine. She has extensive experience in cancer research, having worked at various institutions including Charles River Laboratories and Cincinnati Children's Hospital Medical Center.
Current Role at Asklepios BioPharmaceutical
Jen Barger Fleming currently serves as a Scientist II at Asklepios BioPharmaceutical, Inc. (AskBio), a position she has held since 2021. In this role, she contributes to the development of innovative therapies in the biopharmaceutical sector. Her work involves applying her extensive knowledge in cancer and cell biology to advance research initiatives.
Education and Expertise
Jen Barger Fleming earned her Doctor of Philosophy (PhD) in Cancer & Cell Biology from the University of Cincinnati College of Medicine, completing her studies from 2005 to 2011. She also holds a Bachelor of Science (BS) in Biology from Wright State University, where she studied from 2000 to 2003. This educational background provides her with a strong foundation in biological sciences and research methodologies.
Previous Experience in Research
Prior to her current position, Jen Barger Fleming accumulated significant research experience. She worked as a Research Scientist at Charles River Laboratories from 2016 to 2021. Before that, she was a Postdoctoral Fellow at the Ohio State University Comprehensive Cancer Center from 2013 to 2016. Additionally, she served as a Research Fellow at Cincinnati Children's Hospital Medical Center for one year, from 2012 to 2013.
Early Career and Academic Involvement
Jen Barger Fleming began her academic and research career at the University of Cincinnati, where she was a PhD Candidate from 2005 to 2012. She also worked as a Workshop Curator at the Ohio State University Comprehensive Cancer Center for one year, from 2015 to 2016. Her early involvement in research and education laid the groundwork for her subsequent roles in the field.